Lupin (NSE:LUPIN) Cyclically Adjusted Revenue per Share: ₹494.35 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LUPIN Lupin Ltd NSE:LUPIN
90 GF Score
Price ₹2,250.30
GF Value ₹2,590.06
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lupin Cyclically Adjusted Revenue per Share?

Lupin NSE:LUPIN -1.35% 90 Cyclically Adjusted Revenue per Share is ₹494.35 as of Jun. 2026. GuruFocus rates NSE:LUPIN with a GF Score™ of 90/100 and a GF Value™ of ₹2,590.06 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Lupin's adjusted revenue per share for the three months ended in Jun. 2026 was ₹179.385. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹494.35 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Lupin's average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Lupin was 5.30% per year. The lowest was 4.60% per year. And the median was 5.00% per year.

As of today (2026-08-14), Lupin's current stock price is ₹2250.30. Lupin's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹494.35. Lupin's Cyclically Adjusted PS Ratio of today is 4.55.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Lupin was 5.18. The lowest was 1.48. And the median was 2.71.


Lupin  (NSE:LUPIN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Lupin's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2250.30/494.35
=4.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Lupin was 5.18. The lowest was 1.48. And the median was 2.71.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Lupin Cyclically Adjusted Revenue per Share Related Terms


Lupin Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Lupin's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lupin Cyclically Adjusted Revenue per Share Chart

Lupin Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 400.39 422.19 440.94 457.44 486.82

Lupin Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 465.85 476.67 481.79 486.82 494.35

NSE:LUPIN vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lupin's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lupin Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lupin's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Lupin's Cyclically Adjusted PS Ratio falls into.


NSE:LUPIN
90GF Score
Lupin Ltd NSE:LUPIN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lupin Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lupin's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=179.385/166.1454*166.1454
=179.385

Current CPI (Jun. 2026) = 166.1454.

Lupin Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 94.727 105.961 148.531
201612 97.268 105.196 153.624
201703 93.857 105.196 148.237
201706 83.885 107.109 130.121
201709 85.485 109.021 130.277
201712 85.632 109.404 130.044
201803 89.219 109.786 135.020
201806 83.400 111.317 124.479
201809 85.724 115.142 123.696
201812 84.608 115.142 122.086
201903 83.847 118.202 117.856
201906 83.978 120.880 115.425
201909 84.479 123.175 113.950
201912 82.110 126.235 108.070
202003 81.983 124.705 109.226
202006 76.251 127.000 99.754
202009 83.156 130.118 106.181
202012 86.078 130.889 109.264
202103 82.586 131.771 104.130
202106 93.034 134.084 115.280
202109 88.196 135.847 107.867
202112 89.764 138.161 107.946
202203 84.179 138.822 100.748
202206 79.297 142.347 92.554
202209 89.877 144.661 103.225
202212 92.928 145.763 105.922
202303 94.645 146.865 107.070
202306 103.805 150.280 114.764
202309 108.131 151.492 118.590
202312 111.106 152.924 120.712
202403 106.972 153.035 116.137
202406 120.567 155.789 128.582
202409 120.174 157.882 126.464
202412 122.797 158.323 128.864
202503 121.465 157.552 128.090
202506 134.598 159.755 139.982
202509 149.209 162.289 152.754
202512 155.050 163.281 157.770
202603 161.420 164.272 163.260
202606 179.385 166.145 179.385

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹494.35 mean?
Lupin (NSE:LUPIN) has a Cyclically Adjusted Revenue per Share of ₹494.35 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lupin and its competitors.
Is Lupin's Cyclically Adjusted Revenue per Share too high?
Lupin's current Cyclically Adjusted Revenue per Share is ₹494.35. Overall, Lupin has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lupin's Cyclically Adjusted Revenue per Share compare to ZTS?
Lupin's Cyclically Adjusted Revenue per Share of ₹494.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lupin and its competitors. Lupin's current Cyclically Adjusted Revenue per Share is ₹494.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lupin stock overvalued right now?
Based on GuruFocus' analysis, Lupin (NSE:LUPIN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,590.06, compared to a current price of ₹2,250.30 — trading 13.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹494.35. Lupin's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Lupin (NSE:LUPIN), the current Cyclically Adjusted Revenue per Share is ₹494.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lupin (NSE:LUPIN) Overvalued in 2026?

Based on GuruFocus' analysis, Lupin stock appears to be undervalued. The current stock price of ₹2,250.30 is trading 13.1% below its estimated GF Value™ of ₹2,590.06. GuruFocus considers Lupin to be Modestly Undervalued.

Key valuation signals for NSE:LUPIN:

  • Cyclically Adjusted Revenue per Share: ₹494.35
  • GF Value™: ₹2,590.06 vs. price of ₹2,250.30 (13.1% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the NSE:LUPIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lupin Business Description

Other Exchanges 500257:India
Address Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400055
Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.
90GF Score

Get the complete analysis for NSE:LUPIN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,250.30
Price
₹2,590.06
GF Value